Page 2 - Immunologic Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunologic disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunologic Disease Today - Breaking & Trending Today

Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market

Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market
A new study by MarkNtel Advisors, the Global AI Enabled Drug Discovery & Clinical Trials Market is likely to witness around 23.6% CAGR during 2021-26.
UNITED SATES, July 29, 2021 /EINPresswire.com/ It owes primarily to the rapidly increasing awareness regarding the benefits of AI among medical professionals, the mounting requirements to minimize the drug discovery cost & time, and burgeoning adoption of cloud-based services & applications, owing to which, faster, efficient, & cost-effective drug discovery, is gaining momentum amongst the pharmaceutical industry stakeholders.
Apart from this, delay in patent expiry and expansion of biotechnology industries are other crucial factors likely to enhance the market growth in the years to come. ....

United States , United Kingdom , Saudi Arabia , South Korea , Asia Pacific , Biomarker Research , Markntel Advisors , Global Healthcare Robotics Market Research , Global Imaging Modalities Market Research , Component Software , Cloud Pharmaceuticals , Contract Research Organization Cros , Research Centers , Product Development , K Medical Imaging Market Research , Atomwise Inc , Cyclica Inc , Drug Discovery , Clinical Trials Market , Free Sample , Shammi Thakur , Lead Analyst , North America , Global Artificial Intelligence , Enabled Drug Discovery , Therapeutic Applications ,

ETSU's Dr. Jonathan Moorman receives VA grant to study COVID-19 immune responses

If youâve recovered from COVID-19, you may be able to help researchers at East Tennessee State University learn more about the virus.
Dr. Jonathan Moorman of ETSU was recently awarded a $330,000 Biomedical Laboratory Research and Development Merit Review Award by the Department of Veterans Affairs to study patientsâ immune responses to COVID-19.
His study, âCharacterizing trained immune responses to COVID-19,â was one of 18 studies funded among a pool of 104 applications received from Veterans Affairs Medical Centers across the country. His study will be the second major study to use a biorepository that was established by ETSU and the James H. Quillen Veterans Affairs Medical Center. ....

East Tennessee State University , United States , Jonathan Moorman , Veterans Affairs Medical Centers , Tennessee State University , Development Merit Review Award , Biomedical Laboratory Research , Department Of Veterans Affairs , Lee Coronavirus Task , Jamesh Quillen Veterans Affairs Medical Center , Laboratory Research , Veterans Affairs , Veterans Affairs Medical , Immunologic Disease , Infectious Disease , Bill Lee , Coronavirus Task , கிழக்கு டென்னசி நிலை பல்கலைக்கழகம் , ஒன்றுபட்டது மாநிலங்களில் , ஜொனாதன் மூர்மன் , வீரர்கள் வாழ்க்கைத்தொழில்கள் மருத்துவ மையங்கள் , டென்னசி நிலை பல்கலைக்கழகம் , வளர்ச்சி தகுதி விமர்சனம் விருது , உயிர் மருத்துவ ஆய்வகம் ஆராய்ச்சி , துறை ஆஃப் வீரர்கள் வாழ்க்கைத்தொழில்கள் , ஆய்வகம் ஆராய்ச்சி ,